Arkolith/Insider Trading/FRTX/Form 4

Exploration Capital General Partner, LLC

10% OwnerFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Dec 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$26K
Net Open-Market Flow
-$26K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2023Sell(P)17K$0.90$16K700K
Dec 5, 2023Sell(P)5K$0.85$4K683K
Dec 4, 2023Sell(P)8K$0.85$6K678K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-093858) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML